Study to Evaluate GSK2190915 in Subjects With Mild Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Asthma
Interventions
DRUG

GSK2190915

Investigational Product

Trial Locations (3)

NW10 7EW

GSK Investigational Site, London

W1G 8HU

GSK Investigational Site, London

M23 9QZ

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY